Manar Matar

Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn’s Disease Compared With Reactive Monitoring

Amit Assa, Manar Matar, Dan Turner et al. · Gastroenterology · 2019 · 245 citations

Autoimmune Disease, Increased Clinical Remission, Gastroenterology +7

Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study

Ohad Atia, Zivia Shavit-Brunschwig, Diane R. Mould et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 58 citations

Vedolizumab Treatment, Multicentre Cohort Study, Clinical Epidemiology +7

Combination Therapy of Adalimumab With an Immunomodulator Is Not More Effective Than Adalimumab Monotherapy in Children With Crohn’s Disease: A Post Hoc Analysis of the PAILOT Randomized Controlled Trial

Manar Matar, Raanan Shamir, Dan Turner et al. · Inflammatory Bowel Diseases · 2019 · 36 citations · Full text

Pediatric inflammatory bowel disease and the effect of COVID-19 pandemic on treatment adherence and patients’ behavior

Lev Dorfman, Raouf Nassar, Dalit Binjamin Ohana et al. · Pediatric Research · 2021 · 28 citations · Full text

Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed‐up Study)

Anat Yerushalmy‐Feler, Gemma Pujol‐Muncunill, Javier Martin‐de‐carpi et al. · Journal of Pediatric Gastroenterology and Nutrition · 2022 · 26 citations · Full text